annual meeting program - American Society of Clinical Oncology

SUNDAY
Sunday, June 6, 2010
2:00 PM - 6:00 PM
GENERAL POSTER SESSION
Sarcoma
Location: S Hall A2
Tracks(s): Sarcoma
Brd. 48A Prognostic value of the most frequent mutations in GIST: Results of the
French population-based prospective study MolecGIST. (Abstract #10034)
J. Emile, S. Brahimi, J. Coindre, J. Blay, P. Aegerter, J. Scoazec, G. Viennet,
O. Bouche, L. Doucet, A. Wacrenier
Brd. 48B Combination of targeted therapy (imatinib) with immunotherapy
(peginterferon �-2b) to overcome drug resistance and tumor stem cells in
gastrointestinal stromal tumors (GIST). (Abstract #10035)
L. L. Chen, X. Chen, L. G. Gouw, R. I. Andtbacka, K. A. Jones, J. H. Ward,
R. Randall, J. C. Trent, S. Patel, R. S. Benjamin
Brd. 48C Phase I/II study of TH-302 combined with doxorubicin in soft tissue sarcoma.
(Abstract #10036)
L. D. Cranmer, S. P. Chawla, D. A. Rushing, J. E. Butrynski, S. H. Okuno,
D. Adkins, V. K. Langmuir, G. A. Lorente, S. Kroll, K. N. Ganjoo
Brd. 48D Brostallicin versus doxorubicin as first-line chemotherapy in patients with
advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and
Bone Sarcoma Group randomized phase II study. (Abstract #10037)
H. Gelderblom, J. Blay, B. M. Seddon, M. Leahy, I. L. Ray-Coquard,
A. De brauwer, E. Veyt, S. D. Weitman, P. C. Hogendoorn, P. Hohenberger
Brd. 48E Multicenter, triple-arm, single-stage, phase II trial to determine the efficacy
and safety of everolimus (RAD001) in patients with refractory bone or soft
tissue sarcomas including GIST. (Abstract #10038^)
S. Richter, D. Pink, P. Hohenberger, H. Schuette, P. G. Casali, A. Pustowka,
P. Reichardt
Brd. 48F Identification of oncogenic events in gastrointestinal stromal tumors (GISTs)
by combined gene expression and copy number analysis. (Abstract #10039)
M. Nannini, M. A. Pantaleo, A. Astolfi, A. Maleddu, M. C. Heinrich, C. L. Corless,
M. di Battista, F. Catena, D. Santini, G. Biasco
Brd. 48G Soluble factors (SF) associated with efficacy and toxicity of pazopanib (PZB)
in advanced soft tissue sarcoma (STS) patients (pts): An EORTC-STBSG
study. (Abstract #10040)
S. Sleijfer, M. M. Van Glabbeke, C. Lamers, H. Burger, J. Blay, A. l. Cesne,
M. R. Scurr, A. N. Bartlett-Pandite, S. Marreaud, P. Hohenberger
Brd. 48H Radiofrequency ablation of lung metastases arising from sarcoma.
(Abstract #10041)
J. Palussiere, A. Italiano, A. Avril, E. Descat, N. Bin Bui
Brd. 49A Improvement in the survival for adult soft tissue sarcoma with adjuvant
anthracycline chemotherapy combination: A meta-analysis and
metaregression. (Abstract #10042)
S. L. Afonso, L. A. Ramos, G. A. Viani, E. Stefano, V. Afonso
Brd. 49B BRAF V600E mutations in benign and malignant peripheral nerve sheath
tumors. (Abstract #10043)
C. Serrano, S. Simonetti, J. Hernandez, C. Valverde, J. Carles, S. Bague,
R. Orellana, R. Somoza, S. Ramon y Cajal, C. Romagosa
Brd. 49C Use of a genome-wide single nucleotide polymorphism array-based
chromosomal analysis to evaluate uniparental disomy (UPD) in
gastrointestinal stromal tumors (GIST). (Abstract #10044)
N. Lourenço, J. Emile, S. Brahimi, J. Bachet, F. Jardin, J. Tran van Nhieu,
J. Coindre, C. Penna
280